Executive record

Raul R. Rodriguez

President, Chief Executive Officer and Director at RIGEL PHARMACEUTICALS INC

Follow
More
Challenge a Claim

Alpha ID: alpha:person:raul-r-rodriguezVersion: public-0As of: 2026-09-28

Not yet claimed9 published Claims3 sources
  • Executive
  • Director

Key Claims

Biography

Biography is set forth under the heading Proposal 1 - Election of Directors. Serves as President, CEO, and Director of Rigel Pharmaceuticals.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Current · dates not publishedPresident and Chief Executive Officer · RIGEL PHARMACEUTICALS INC
  2. 2026 to end not publishedExecutive title: President, Chief Executive Officer and Director · Organization not publishedRIGL DEF 14A executive officers
  3. Dates not publishedExecutive title: President and Chief Executive Officer · Organization not published

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. RIGL DEF 14A executive officers

    sec filing · Source published: Apr 3, 2026 · Retrieved: May 5, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Executive company: Executive at RIGEL PHARMACEUTICALS INC · Claim reviewed: May 5, 2026
    • Executive title: Executive title: President, Chief Executive Officer and Director · Claim reviewed: May 5, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026

  2. Open source

    sec def 14a · Source published: Apr 3, 2026 · Retrieved: Sep 12, 2026

    Supports 3 claims
    • Professional Role: President, Chief Executive Officer and Director at RIGEL PHARMACEUTICALS INC · Claim reviewed: Sep 12, 2026
    • Professional Role: President and Chief Executive Officer at RIGEL PHARMACEUTICALS INC · Claim reviewed: Sep 12, 2026
    • Executive title: Executive title: President and Chief Executive Officer · Claim reviewed: Sep 12, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of RIGEL PHARMACEUTICALS INC · Claim reviewed: Sep 12, 2026